Curium completes acquisition of Belgian firm Abscint
- Location
- Liège · 🇺🇸 USA / Belgium
- Sector
- Pharma
- Organisations
- Curium ↔ Abscint SA
- Transaction
- Acquisition (completed)
- Volume
- Purchase price not disclosed
- Status
- completed
Radiopharmaceutical group Curium has completed the acquisition of Belgian company Abscint SA of Liège. The deal transfers global rights to ABS-011, a gallium-68-labelled PET diagnostic tracer targeting HER2 that is in a Phase 2b trial and aimed at breast and gastric cancers. The purchase price was not disclosed.
Source: biospace.com ↗ · Archived copy ↗
Evidence: one source · archived copy saved · How well sourced is Eurotrack?
More from: 🇺🇸 USA · 🇧🇪 Belgium